文献速递睡眠呼吸障碍

探索非CPAP治疗新途径与阻塞性睡眠呼吸暂停综合管理

Novel avenues to approach non-CPAP therapy and implement comprehensive obstructive sleep apnoea care.
PubMed 文献 · Eur Respir J · 2022-06-02

该综述总结OSA病理生理学、转化研究及非CPAP治疗进展,提出基于临床表型和内型分型的精准医学框架,以改善下颌前移装置、上气道手术、舌下神经刺激等疗法成功率,并强调电子健康与人工智能的辅助作用。

要点

  • OSA临床表型与内型分型可指导非CPAP个体化治疗。
  • 精准医学框架有助于提高下颌前移装置和上气道手术成功率。
  • 电子健康与人工智能将推动风险分层和个性化治疗分配。

核心结论

  • 基于OSA临床表型和内型分型的精准医学策略可优化非CPAP治疗选择并提高成功率。

研究设计与样本

  • 综述总结OSA病理生理、非CPAP治疗及临床管理进展,并指出未来研究的知识空白。

主要发现

  • 识别OSA临床表型和内型有助于理解机制并指导精准治疗。
  • 精准医学框架可改善下颌前移装置和上气道手术等非CPAP疗法的成功率。
  • 新概念揭示部分患者CPAP依从性的潜在生理障碍。

临床怎么用

  • 临床可基于表型和内型分型为OSA患者选择非CPAP个体化治疗方案。
  • 利用风险分层和个性化治疗分配策略提高治疗成功率。

局限性

  • 综述指出未来研究需填补OSA发病机制、非CPAP治疗及管理方面的知识空白。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recent advances in obstructive sleep apnoea (OSA) pathophysiology and translational research have opened new lines of investigation for OSA treatment and management. Key goals of such investigations are to provide efficacious, alternative treatment and management pathways that are better tailored to individual risk profiles to move beyond the traditional continuous positive airway pressure (CPAP)-focused, "one size fits all" trial-and-error approach, which is too frequently inadequate for many patients. Identification of different clinical manifestations of OSA (clinical phenotypes) and underlying pathophysiological phenotypes (endotypes) that contribute to OSA have provided novel insights into underlying mechanisms and have underpinned these efforts. Indeed, this new knowledge has provided the framework for precision medicine for OSA to improve treatment success rates with existing non-CPAP therapies such as mandibular advancement devices and upper airway surgery, and newly developed therapies such as hypoglossal nerve stimulation and emerging therapies such as pharmacotherapies and combination therapy. Additionally, these concepts have provided insight into potential physiological barriers to CPAP adherence for certain patients. This review summarises the recent advances in OSA pathogenesis, non-CPAP treatment, clinical management approaches and highlights knowledge gaps for future research. OSA endotyping and clinical phenotyping, risk stratification and personalised treatment allocation approaches are rapidly evolving and will further benefit from the support of recent advances in e-health and artificial intelligence.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Pépin JL, Eastwood P, Eckert DJ, et al. Novel avenues to approach non-CPAP therapy and implement comprehensive obstructive sleep apnoea care. Eur Respir J. 2022. PMID: 34824053. doi:10.1183/13993003.01788-2021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。